DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in JNJ — Johnson & Johnson
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,365,928,118
-$142,957,954 QoQ
Shares Held
5,378,305
-12.9% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#46
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Sep 30, 2023CallValue
$78,498,000
CallShares
504,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $6,628,918,596 across 11 Drug Manufacturers - General names. JNJ ranks #3 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
11,720,479 | $2,222,437,225 | |
| 2 | LLY |
ELI LILLY & Co
|
1,338,915 | $1,605,934,947 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
5,378,305 | $1,365,928,118 | |
| 4 | ABBV |
AbbVie Inc.
|
2,885,557 | $726,121,560 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,628,110 | $332,035,416 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,506,793 | $193,622,900 | |
| 7 | AMGN |
Amgen Inc
|
278,356 | $100,798,272 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
895,583 | $51,603,492 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,365,928,118 | 5,378,305 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,508,886,072 | 6,172,828 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $587,454,682 | 2,838,631 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $983,752,480 | 5,305,536 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $819,998,199 | 5,368,237 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $868,485,835 | 5,236,890 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $127,568,865 | 882,097 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $170,687,422 | 1,053,236 | Shares | Defined | 2026-05-04 | |
| 2024-06-30 | $147,480,553 | 1,009,035 | Shares | Defined | 2026-05-04 | |
| 2024-03-31 | $159,213,803 | 1,006,472 | Shares | Sole | 2026-05-04 | |
| 2023-12-31 | $189,195,835 | 1,207,068 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $78,498,000 | 504,000 | Call | Defined | 2026-05-04 | |
| 2023-09-30 | $192,952,130 | 1,238,858 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $248,946,215 | 1,504,025 | Shares | Defined | 2026-05-04 | |
| 2023-03-31 | $310,314,960 | 2,002,032 | Shares | Defined | 2026-05-04 | |
| 2022-12-31 | $1,082,507,135 | 6,127,977 | Shares | Defined | 2026-05-04 | |
| 2022-09-30 | $982,065,917 | 6,011,667 | Shares | Defined | 2026-05-04 | |
| 2022-06-30 | $1,083,201,696 | 6,102,201 | Shares | Sole | 2026-05-04 | |
| 2022-03-31 | $710,481,215 | 4,008,809 | Shares | Defined | 2026-05-04 | |
| 2021-12-31 | $923,039,658 | 5,395,684 | Shares | Sole | 2026-05-04 | |
| 2021-09-30 | $1,268,258,206 | 7,852,992 | Shares | Defined | 2026-05-04 | |
| 2021-06-30 | $827,697,742 | 5,024,267 | Shares | Defined | 2026-05-04 | |
| 2021-03-31 | $879,901,792 | 5,353,829 | Shares | Defined | 2026-05-04 | |
| 2020-12-31 | $539,957,870 | 3,430,918 | Shares | Sole | 2026-05-04 | |
| 2020-09-30 | $260,917,408 | 1,752,535 | Shares | Defined | 2026-05-04 | |
| 2020-06-30 | $223,610,837 | 1,590,065 | Shares | Defined | 2026-05-04 | |
| 2020-03-31 | $185,255,740 | 1,412,764 | Shares | Defined | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||